Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep-Oct;34(5):475-479.
doi: 10.4103/0970-2113.213824.

Familial interstitial pulmonary fibrosis in two different families in India: A case series

Affiliations

Familial interstitial pulmonary fibrosis in two different families in India: A case series

Dabhi Pradipkumar et al. Lung India. 2017 Sep-Oct.

Abstract

Introduction: Idiopathic pulmonary fibrosis (IPF), a chronic progressive interstitial lung disease (ILD), Occasionally, IPF occurs in families. Familial interstitial lung disease has been reported worldwide, limited information is available on the disease among Indian patients.

Case presentation: A 59-year-old woman presented with a 2-year history of progressive dyspnoea. Based on clinical and radiological features, our patient was diagnosed with idiopathic pulmonary fibrosis. Several family members of her first and second generations had died from respiratory failure. Her sister also diagnosed as IPF based on typical High resolution computed tomography (HRCT) finding though she was asymptomatic and came for screening. In addition, another male patient also had similar history and diagnosed as familial IPF based on HRCT and genetic testing in spite of significant occupational exposure. Genetic study revealed SFTPA1 gene was associated with susceptibility to idiopathic pulmonary fibrosis.

Conclusion: Our report illustrates that asymptomatic screening of family member can uncover such a serious disease in patients with familial interstitial fibrosis. Otherwise, clinical, radiological, and histological features are indistinguishable from those of sporadic cases. Furthermore, our work highlights the importance of compiling a thorough family history in individuals presenting with cough and dyspnoea, particularly in younger patients identified with idiopathic pulmonary fibrosis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Pedigree of family 1 evaluated for FIPF with four affected members. Dark shading indicates the affected family members
Figure 2
Figure 2
Case 1 - (a) High-resolution computed tomography scan obtained at the upper lobe shows reticular opacities and honeycombing. (b) High-resolution computed tomography scan from the basal parts of the lungs showing reticulations and traction bronchiectasis
Figure 3
Figure 3
Case 2 - (a) High-resolution computed tomography scan obtained at the upper lobe shows reticular opacities and honeycombing. (b) High-resolution computed tomography scan prone cuts from the basal parts of the lungs showing reticular and nodular densities, and traction bronchiectasis
Figure 4
Figure 4
Pedigree of family 2 evaluated for FIPF with five affected members. Dark shading indicates the affected family members
Figure 5
Figure 5
Case 3 - (a) High-resolution computed tomography scan obtained at the upper lobe shows reticular opacities, ground-glass attenuation and honeycombing. (b) High-resolution computed tomography scan from the basal parts of the lungs showing ground-glass attenuation, reticular and nodular densities, and traction bronchiectasis

References

    1. Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1172–8. - PubMed
    1. Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE, Jr, et al. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest. 2004;125:2169–74. - PubMed
    1. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, et al. A placebo-controlled trial of interferon gamma-1bin patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004;350:125–33. - PubMed
    1. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med. 2001;345:517–25. - PubMed
    1. Singh V, Sharma BB. Laying the ground for research of interstitial lung disease in our country: ILD India registry. Lung India. 2014;31:320–2. - PMC - PubMed